申请人:SCHERING CORP
公开号:WO2003091220A1
公开(公告)日:2003-11-06
The invention described herein are compounds in accordance with formula I:. I Iwherein R1, R2, R3, R4, R5, R6, R2, R8, R9, n, X, and Z are as defined herein, pharmaceutical compositions containing at least one compound of formula I, methods of preparation thereof, and methods of treating disorders with at least one compound of formula I or at least one compound of formula I in association with at least one acetylcholinesterase inhibitor.
本发明涉及符合以下式I的化合物:I I其中R1、R2、R3、R4、R5、R6、R2、R8、R9、n、X和Z如本文所定义,包含至少一种式I化合物的药物组合物,其制备方法,以及使用至少一种式I化合物或至少一种式I化合物与至少一种乙酰胆碱酯酶抑制剂联合治疗疾病的方法。